発表論文：2011年～

英文論文

1. Jiang D, Matsuzaki M, Ida T, Kitamura K, Kato J. Effects of vasodilators on beat-to-beat and every fifteen minutes blood pressure variability induced by noradrenaline infusion in rats. Hypertens Res 2024, in press
2. Jiang D, Matsuzaki M, Ida T, Kitamura K, Tsuruda T, Kaikita K, Kato J. Natriuretic peptides potentiate cardiac hypertrophic response to noradrenaline in rats. Peptides 2023; 166: 171035.
3. Nakagami S, Notaguchi M, Kondo T, Okamoto S, Ida T, Sato Y, Higashiyama T, Tsai AY, Ishida T, Sawa S. Root-knot nematode modulates plant CLE3-CLV1 signaling as a long-distance signal for successful infection. Sci Adv 2023; 9: eadf4803.
4. Jiang D, Matsuzaki M, Kawagoe Y, Kitamura K, Tsuruda T, Kaikita K, Asada Y, Kato J. Analysis of mechanisms for increased blood pressure variability in rats continuously infused with angiotensin II. J Renin Angiotensin Aldosterone Syst 2023; 2023: 4201342.
5. Yazawa T, Islam MS, Imamichi Y, Watanabe H, Yaegashi K, Ida T, Sato T, Kitano T, Matsuzaki S, Umezawa A, Muranishi Y. Comparison of placental HSD17B1 expression and its regulation in various mammalian species. Animals (Basel) 2023; 13: 622.
6. Kobayashi M, Maruyama N, Yamamoto Y, Togawa T, Ida T, Yoshida M, Miyazato M, Kitada M, Hayashi Y, Kashiwagi A, Kitamura T. A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon-derived peptide levels. J Diabetes Investig 2023; 14: 648-658.
7. Sato T, Ida T, Shiimura Y, Matsui K, Oishi K, Kojima M. Insights Into the Regulation of Offspring Growth by Maternally Derived Ghrelin. Front Endocrinol (Lausanne). 2022; 13: 852636.
8. Nishikimi T, Kato J. Cardiac peptides-current physiology, pathophysiology,biochemistry, molecular biology, and clinical application. Biology 2022; 11:330.
9. Tsuruda T, Yamashita A, Otsu M, Koide M, Nakamichi Y, Sekita-Hatakeyama Y,Hatakeyama K, Funamoto T, Chosa E, Asada Y, Udagawa N, Kato J, Kitamura K.Angiotensin II induces aortic rupture and dissection in osteoprotegerin-deficient mice. J Am Heart Assoc 2022; 11: e025336.
10. Islam MS, Uwada J, Hayashi J, Kikuya KI, Muranishi Y, Watanabe H, Yaegashi K, Hasegawa K, Ida T, Sato T, Imamichi Y, Kitano T, Miyashiro Y, Khan RI, Takahashi S, Umezawa A, Suzuki N, Sekiguchi T, Yazawa T. Analyses of Molecular Characteristics and Enzymatic Activities of Ovine HSD17B3. Animals (Basel). 2021; 11: 2876.
11. Kato J, Kawagoe Y, Jiang D, Ida T, Shimamoto S, Igarashi K, Kitamura K. Plasma adrenomedullin level and year-by-year variability of body mass index in the general population. Peptides 2021; 142: 170567.
12. Sakai N, Ohno H, Yoshida M, Iwamoto E, Kurogi A, Jiang D, Sato T,Miyazato M, Kojima M, Kato J, Ida T. Characterization of putative tachykinin peptides in Caenorhabditis elegans. Biochem Biophys Res Commun 2021; 559:197-202.
13. Kuroishi N, Nagata S, Akashi E, Ashizuka S, Kato J, Yamasaki M,Kitamura K. Development of a novel human adrenomedullin derivative: human serum albumin-conjugated adrenomedullin. J Biochem 2021; 170: 445-451.
14. Ohta Y, Kamide K, Hanada H, Morimoto S, Nakahashi T, Takiuchi S, IshimitsuT, Tsuchihashi T, Soma M, Tomohiro Katsuya T, Sugimoto K, Rakugi H, OukuraT, Higaki J, Matsuura H, Shinagawa T, Miwa Y, Sasaguri T, Igase M, Miki T,Takeda K, Higashiura K, Shimamoto K, Katabuchi R, Ueno M, Hosomi N, Kato J,Komai N, Kojima S, Sase K, Iwashima Y, Yoshihara F, Horio T, Nakamura S,Nakahama H, Miyata T, Kawano Y. Genetic factors associated with elevation ofuric acid after treatment with thiazide-like diuretic in patients withessential hypertension. Hypertens Res 2020; 43: 220-226.
15. Kato J. Natriuretic peptides and neprilysin inhibition in hypertension and hypertensive organ damage. Peptides 2020; 132: 170352.
16. Jiang D, Kawagoe Y, Asada Y, Kitamura K, Kato J. Augmented blood pressure variability following continuous infusion of noradrenaline in rats. J Hypertens 2020; 38: 314–321.
17. Tsuruda T, Kato J, Kuwasako K, Kitamura K. Adrenomedullin: Continuing to explore cardioprotection. Peptides 2019; 111: 47-54.
18. Kuwasako K, Kitamura K, Nagata S, Sekiguchi T, Danfeng J, Murakami M, Hattori Y, Kato J. β-arrestins negatively control human adrenomedullin type 1-receptor internalization. Biochem Biophys Res Commun 2017; 487: 438-443.
19. Ohno H, Yoshida M, Sato T, Kato J, Miyazato M, Kojima M, Ida T, Iino Y. Luqin-like RYamide peptides regulate food-evoked responses in C. elegans. eLife 2017; 6: e28877.
20. Jiang D, Kawagoe Y, Kuwasako K, Kitamura K, Kato J. Inhibitory effects of losartan and azelnidipine on augmentation of blood pressure variability induced by angiotensin II in rats. Eur J Pharmacol 2017; 806: 91-95.
21. Kuwasako K, Sekiguchi T, Nagata S, Jiang D, Hayashi H, Murakami M, Hattori Y, Kitamura K, Kato J. Inhibitory effects of two G protein-coupled receptor kinases on the cell surface expression and signaling of the human adrenomedullin receptor. Biochem Biophys Res Commun 2016; 470: 894-899.
22. Kato J, Kawagoe Y, Jiang D, Kuwasako K, Shimamoto S, Igarashi K, Tokashiki M, Kitamura K. Plasma levels of natriuretic peptides and year-by-year blood pressure variability: a population-based study. J Hum Hypertens 2017; 31: 525-529.
23. Sekiguchi T, Shiraishi A, Satake H, Kuwasako K, Takahashi H, Sato M, Urata M, Wada S, Endo M, Ikari T, Hattori A, Srivastav AK, Suzuki N. Calcitonin- typical suppression of osteoclastic activity and amphioxus calcitonin superfamily paptides and insights into the evolutionary conservation and diversity of their structures. Gen Comp Endocrinol 2017;
    246: 294-300.
24. Tsuruda T, Sekita-Hatakeyama Y, Hao Y, Sakamoto S, Kurogi S, Nakamura M, Udagawa N, Funamoto T, Sekimoto T, Hatakeyama K, Chosa E, Kato J, Asada Y, Kitamura K. Angiotensin II stimulation of cardiac hypertrophy and functional decompensation in osteoprotegerin-deficient mice. Hypertension 2016; 67: 848-56.
25. Kuwasako K, Sekiguchi T, Nagata S, Jiang D, Hayashi T, Murakami M, Hattori Y, Kitamura K, Kato J. Inhibitory effects of two G protein-coupled receptor kinases on the cell surface expression and signaling of the human adrenomedullin receptor. Biochem Biophys Res Commun 2016; 470: 894-899
26. Sekiguchi T, Kuwasako K, Ogasawara M, Takahashi H, Matsubara S, Osugi T, Muramatsu I, Sasayama Y, Suzuki N, Satake H. Evidence for conservation of the calcitonin superfamily and activity-regulating mechanisms in the basal chordate Branchiostoma floridae: insight into the molecular and functional evolution in chordates. J Biol Chem 2016; 291: 2345-2356
27. Ogawa N, Komura H, Kuwasako K, Kitamura K, Kato J. Plasma levels of natriuretic peptides and development of chronic kidney disease. BBMC Nephrol 2015; 16: 171.
28. Jiang D, Tokashiki M, Hayashi H, Kawagoe Y, Kuwasako K, Kitamura K, Kato J. Augmented blood pressure variability in hypertension induced by angiotensin II in rats. Am J Hypertens 2016; 29: 163-169.
29. Kato J, Kitamura K. Bench-to-bedside pharmacology of adrenomedullin. Eur J Pharmacol 2015; 764: 140-8.
30. Murakami M, Suzuki T, Wu TW, Kuwasako K, Takahashi E, Watanabe H, Murakami AM, Miyoshi I, Yanagisawa T, Sasano H, Ono K, Ohba T. Modified autonomic regulation in mice mutated in the β4 subunit of the lh/lh calcium channel.Biochem Biophys Res Commun 2015; 461: 200-205.
31. Murakami M, Yoshikawa T, Nakamura T, Ohba T, Matsuzaki Y, Sawamura D, Kuwasako K, Yanagisawa T, Ono K, Nakaji S, Yanai K. Involvement of the histamine H1 receptor in the regulation of sympathetic nerve activity. Biochem Biophys Res Commun 2015, 458: 584-589.
32. Kawano S, Kawagoe Y, Kuwasako K, Shimamoto S, Igarashi K, Tokashiki M, Kitamura K, Kato J. Gender-related alterations in plasma adrenomedullin level and its correlation with body weight gain. Endocr Connect 2015, 4: 42-49..
33. Shintaku T, Ohba T, Niwa H, Kushikata T, Hirota K, Onao K, Matsuzaki Y, Imaizumi T, Kuwasako K, Sawamura D, Murakami M. Effects of propofol on electrocardiuogram measures in mice. J Pharmacol Sci 2014; 126: 351-358.
34. Koyama S, Tsuruda T, Ideguchi T, Kawagoe J, Onitsuka H, Ishikawa T, Date H, Hatakeyama K, Asada Y, Kato J, Kitamura K. Osteoprotegerin is Secreted Into the Coronary Circulation: A Possible Association with the Renin-Angiotensin System and Cardiac Hypertrophy. Horm Metab Res. 2014, 46: 581-586.
35. Kato J. Natriuretic peptides. In: Caplan M, ed. Reference Module in Biomedical Sciences, Elsevier, London, 2014, doi:10.1016/B978-0-12-801238-3.03972-6
36. Kubo K, Tokashiki M, Kuwasako K, Tamura M, Tsuda S, Kubo S, Yoshizawa-Kumagaye K, Kato J, Kitamura K. Biological properties of adrenomedullin conjugated with polyethylene glycol.Peptides. 2014; 57: 118-121
37. Kato J, Kitamura K: Adrenomedullin Peptides. In: Kastin AJ, ed. Handbook of Biologically Active Peptides, Academic Press, San Diego, p.1361-1368, 2013
38. Kuwasako K, Hay DL, Nagata S, Murakami N, Kitamura K, Kato J. Functions of the extracellular loop and helix 8 of Family B GPCRs complexed with RAMPs and characteristics of their receptor trafficking. Curr Protein Pept Sci 2013; 14: 416-428
39. Kuwasako K. The RAMP-interacting Family B G protein-coupled receptors and their specific bioactive peptides. Curr Protein Pept Sci 2013; 14: 243-245
40. Komura H, Nomura I, Kitamura K, Kuwasako K, Kato J. Gender difference in relationship between body mass index and development of chronic kidney disease. BMC Res Notes. 2013 Nov 13;6(1):463
41. Nagata S, Hatakeyama K, Asami M, Tokashiki M, Hibino H, Nishiuchi Y, Kuwasako K, Kato J, Asada Y, Kitamura K. Big angiotensin-25: A novel glycosylated angiotensin-related peptide isolated from human urine. Biochem Biophys Res Commun. 2013; 441: 757-762
42. Moniwa N, Varagic J, Ahmad S, VonCannon JL, Simington SW, Wang H, Groban L, Brosnihan KB, Nagata S, Kato J, Kitamura K, Gomez RA, Lopez ML, Ferrario CM. Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension. Hypertension 2013; 61: 417-424
43. Yamaguchi M, Tsuruda T, Watanabe Y, Onitsuka H, Furukawa K, Ideguchi T, Kawagoe J, Ishikawa T, Kato J, Takenaga M, Kitamura K. Reduced fractional shortening of right ventricular outflow tract is associated with adverse outcomes in patients with left ventricular dysfunction. Cardiovasc Ultrasound. 2013 Jun 3;11(1):19
44. Kamide K, Asayama K, Katsuya T, Ohkubo T, Hirose T, Inoue R, Metoki H, Kikuya M, Obara T, Hanada H, Thijs L, Kuznetsova T, Noguchi Y, Sugimoto K, Ohishi M, Morimoto S, Nakahashi T, Takiuchi S, Ishimitsu T, Tsuchihashi T, Soma M, Higaki J, Matsuura H, Shinagawa T, Sasaguri T, Miki T, Takeda K, Shimamoto K, Ueno M, Hosomi N, Kato J, Komai N, Kojima S, Sase K, Miyata T, Tomoike H, Kawano Y, Ogihara T, Rakugi H, Staessen JA, Imai Y; GEANE study group; HOMED-BP study group. Genome-wide response to antihypertensive medication using home blood pressure measurements: a pilot study nested within the HOMED-BP study. Pharmacogenomics. 2013 Nov;14(14):1709-1721
45. Kato J, Yokota N, Tamaki N, Kariya S, Kita T, Ayabe T, Eto T, Kitamura K. Differential blood pressure reductions by angiotensin receptor blocker plus calcium channel blocker or diuretic in elderly hypertension with or without obesity. J Am Soc Hypertens 2012; 6: 393-398
46. Kita T, Yokota N, Ichiki Y, Ayabe T, Etoh T, Tamaki N, Kato J, Eto T, Kitamura K. Three-year safety and effectiveness of fixed-dose losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension under clinical setting (PALM-1 Extension Study). Clin Exp Hypertens 2012; 34: 498-503
47. Ida T, Takahashi T, Tominaga H, Sato T, Sano H, Kume K, Ozaki M, Hiraguchi T, Shiotani H, Terajima S, Nakamura Y, Mori K, Yoshida M, Kato J, Murakami N, Miyazato M, Kangawa K, Kojima M. Isolation of the bioactive peptides CCHamide-1 and CCHamide-2 from Drosophila and their putative role in appetite regulation as ligands for G-protein-coupled receptors. Frontiers in Eendocrinol 2012; 3: 1-7
48. Kuwasako K, Kitamura K, Nagata S, Nozaki N, Kato J. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization. Biochem Biophys Res Commun 2012; 420: 582-587
49. KomatsuY, Kida N, Nozaki N, Kuwasako K, Nagata S, Kitamura K, Kato J. Effects of proangiotensin-12 infused continuously over 14 days in conscious rats. Eur J Pharmacol 2012; 683: 186-189
50. Kawano S, Kato J, Kawano N, Yoshimura Y, Masuyama H, Fukunaga T, Shimao Y, Mihara K, Ueda A, Toyoda K, Imamura T, Kitamura K. Sarcoidosis manifesting as cardiac sarcoidosis and massive splenomegaly. Intern Med 2012; 51: 65-69
51. Kuwasako K, Hay DL, Nagata S,Hikosaka T, Kitamura K, Kato J. The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling. Brit J Pharmacol 2012; 166: 137-150
52. Nagata S, Kato J, Kuwasako K, Kitamura K. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system. Hypertens Res 2012; 35: 234-238
53. Ida T, Takahashi T, Tominaga H, Sato T, Kume K, Yoshizawa-Kumagae K, Nishio H, Kato J, Murakami N, Miyazato M, Kangawa K, Kojima M. Identification of the endogenous cysteine-rich peptide trissin, a ligand for an orphan G protein-coupled receptor in Drospphila. Biochem Biophys Res Commun 2011; 44: 44-48
54. Hikosaka T, Tsuruda T, Nagata S, Kuwasako K, Tsuchiya K, Hoshiko S, Inatsu H, Chijiwa K, Kitamura K. Adrenomedullin production is increased in colorectal adenocarcinomas; its relation to matrix metalloproteinase-9. Peptides 2011; 32: 1825-31
55. Kato J, Kuwasako K, Kitamura K. Adrenomedullin in hypertension and obesity. Curr Hypertens Rev 2011; 7: 257-267
56. Kuwasako K, Kitamura K, Nagata S, Kato J. Molecular basis of adrenomedullin 1 receptor function and its roles in the cardiovascular system. Curr Hypertens Rev 2011; 7: 207-216
57. Kuwasako K, Kitamura K, Nagata S, Hikosaka T, Takei Y, Kato J. Shared and separate functions of the RAMP-based adrenomedullin receptors. Peptides 2011; 32: 1540-1550
58. Ida T, Takahashi T, Tominaga H, Sato T, Kume K, Ozaki M, Hiraguchi T, Maeda T, Shiotani H, Terajima S, Sano H, Mori K, Yoshida M, Miyazato M, Kato J, Murakami N, Kangawa k, Kojima M. Identification of the novel bioactive peptides dRYamide-1 and dRYamide-2, ligands for a neuropeptide Y-like receptor in Drosophila. Biochem Biophys Res Commun 2011; 410: 872-877
59. Kawano S, Kato J, Kawano N, Yoshimura Y, Masuyama H, Fukunaga T, Maruyama H, Mihara K, Ueda A, Toyoda K, Imamura T, Kitamura K. Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period. Intern Med 2011; 50: 975-981
60. Kato J, Yokota N, Tamaki N, Kariya S, Kita T, Ayabe T, Eto T, Kitamura K. Comparison of combination therapies, including the angiotensin receptor blocher olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension. Hypertens Res 2011; 34: 331-335
61. Kuwasako K, Kitamura K, Nagata S, Hikosaka T, Kato J. Structure-function analysis of hlix 8 human calcitonin receptor-like receptor within adrenomedullin 1 receptor. Peptides 2011; 32: 144-149

邦文論文

1. 加藤丈司、姜　丹鳳、川越由紀子、桑迫健二：食塩摂取量増加に伴う血圧変動性増大のモデル動物の開発と機序解明および治療手段探索．平成29年度公益財団法人ソルト・サイエンス研究財団助成研究報告書　2019; 87-92
2. 加藤丈司．清武地域における23年間の健診結果の解析と今後の課題．宮崎県医師会医学会誌 2016; 40: 15-23.
3. 野﨑尚美、木田信章、桑迫健二、北村和雄、加藤丈司. メタボリックシンドローム対策としての特定健診の有用性－清武町研究－. 宮崎県医師会医学会誌 2012; 36: 14-18.

邦文総説・著書

1. 加藤丈司、姜　丹鳳．血圧変動性増大の動物モデルの開発．Medical Science Digest2019; 45: 283-284.
2. 加藤丈司．関連トピックス　高血圧バイオマーカーとしての循環調節ペプチド．medicina 2016; 53: 1755.
3. 加藤丈司．JSH 2014：高血圧治療ガイドライン改訂のポイント．宮崎県内科医会誌 87: 6-11, 2015
4. 加藤丈司、桑迫健二、小松洋一、永田さやか、北村和雄．プロアンジオテンシン-12研究の最前線．Angiology Frontier 2014; 13: 13-18.
5. 加藤丈司．JNCのガイドラインが推奨する降圧治療.　循環器内科 74, 384-389, 2013
6. 加藤丈司．自己紹介と生理活性ペプチド研究紹介．宮崎県内科医会誌 2013: 84, 2-6.
7. 加藤丈司．アドレノメデュリンと関連ペプチド． 血圧 19: 890-894, 2012
8. 井田隆徳、児島将康、加藤丈司. 未知の生理活性ペプチドの探索および機能解析の研究モデル生物を利用して. ペプチド医薬の最前線. 木曽良明、向井秀仁、シーエムシー出版 47-51, 2012
9. 桑迫健二、北村和雄、永田さやか、加藤丈司. 1型アドレノメデュリン受容体複合体のユニークな分子機構と循環制御. 日本薬理学雑誌 140: 8-13, 2012（依頼原稿，査読有り）
10. 野村郁夫、 加藤丈司、北村和雄．一般住民における血中アルドステロン値の規定因子および血中アルドステロン値とインスリン感受性との関連．血圧 18: 771-773, 2011
11. 加藤丈司. ARBの併用薬はCa拮抗薬か利尿薬か. 血圧 18: 810-811, 2011
12. 加藤丈司、北村和雄．二次性高血圧． 臨牀と研究 88: 205-208, 2011